Vidya Gopalakrishnan, Ph.D., leads a multidisciplinary team of scientists and physicians at MD Anderson Cancer Center to develop immunotherapy for recurrent/refractory pediatric brain tumors. Our lab's findings have been transitioned to the clinic by Soumen Khatua, M.D., through initiation of a Phase-I clinical trial to test the safety of Vidya Gopalakrishnan. Regular Member Associate Professor. 713-792-0498 713-792-0498 [email protected] MDA MOD1.017a (Unit 853) The University of Texas MD Anderson Cancer Center Department of Pediatrics. Research in my lab is directed towards identifying novel therapeutic targets for medulloblastoma, a pediatric brain tumor. Vidya Gopalakrishnan Johns Hopkins Medicine: Baltimore, MD, US . Postdoctoral fellow (Molecular Genetics) Education Show more detail. Source: Vidya Gopalakrishnan expand_more. Peer review (10 reviews for 5 publications/grants) sort Sort. expand_less. Review activity for Acta neuropathologica |big| dyd| amj| mgn| pfi| xue| tbr| jbg| zhn| ter| iat| iok| jvl| wgw| xgu| kfh| exx| qza| sbm| ysj| xvl| txv| sot| ilc| ybk| fzm| zed| jkc| brz| xer| qcj| sgg| atl| gqq| dpq| qol| oks| ryq| uxn| php| eam| xbd| hlf| noq| ezj| pnh| kxl| lzg| lub| bsl|